Genor Biopharma Holdings Limited (6998.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
| Market Cap | 4.51B |
| Enterprise Value | 4.94B |
| P/E Ratio | 6.6 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.3 |
| Price/Book Ratio | 0.53 |
| Enterprise/Revenue | 0.46 |
| Enterprise/EBITDA | 1.59 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.16 |
| Operating Margin | 0.29 |
| Return On Assets | 0.07 |
| Return On Equity | 0.18 |
| Revenue | 2.7B |
| Revenue/Share | 2.06 |
| Gross Profit | 1.76B |
| EBITDA | 954.29M |
| Net Income | 433.01M |
| Diluted EPS | 0.22 |
| Total Cash | 1.06B |
| Total Cash/Share | 0.8 |
| Total Debt | 1.49B |
| Total Debt/Equity | 0.39 |
| Current Ratio | 1 |
| Book Value Per Share | 2.91 |
| 52-Week Change | -28.85 |
| 52-Week High | 3.64 |
| 52-Week Low | 1.54 |
| Moving Average 50 Days | 2.5 |
| Moving Average 200 Days | 2.62 |
| Average Volume | 2.29M |
| Shares Outstanding | 524.62M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.11 |
| Last Split Factor | N/A |
| Last Split Date | N/A |